Bone marrow ‐derived mononuclear cell therapy for non‐ischemic dilated cardiomyopathy: a meta‐analysis
ConclusionsBMMNCs transplantation is associated with a moderate, but significant, improvement in LVEF in patients with non‐ischemic DCM. This meta‐analysis supports further RCT conductions using BMMNCs transplantation with larger patient's population and longer‐term follow‐up.This article is protected by copyright. All rights reserved.
Source: European Journal of Clinical Investigation - Category: General Medicine Authors: Yanting Wen, Jingjing Ding, Bin Zhang, Qian Gao Tags: Original Paper Source Type: research
More News: Cardiology | Cardiomyopathy | Dilated Cardiomyopathy | General Medicine | Heart | Stem Cell Therapy | Stem Cells | Study | Transplants